Families' Experiences of Paediatric ICC Diagnosis
NCT02737111 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2016-05-10
Summary
This study aims to further understand the experiences of children, their parents and siblings around the time when the child and their family are informed of a diagnosis of an inherited cardiac condition (ICC). The researchers are interested to understand how families experience the process of receiving a diagnosis of an ICC, and explore experiences from multiple perspectives within the family (i.e. parents, children and siblings).
The Primary Project Objective:
How do children, their parents and siblings experience the communication of a diagnosis of an inherited cardiac condition (ICC)? What is found to be helpful and less helpful?
The Secondary Project Objective:
To explore qualitatively how families experience the communication of a positive diagnosis for an inherited cardiac condition for a child and will seek the perspectives of the child with the diagnosis, their siblings and parents.
Conditions
- Inherited Cardiac Conditions
Interventions
- BEHAVIORAL
-
Information and Informed Consent
The researcher will contact parents of patients who agreed some weeks after receiving the diagnosis, check inclusion criteria, and information sheets will be provided. Individuals who consent to participate will arrange to meet with the researcher in their family home or at the hospital. When they meet, the researcher will go through the participant information sheet with the individuals, and gain written consent for participation
- BEHAVIORAL
-
Initial Screening Process
The doctor who meets with the family to share the diagnosis will give the participants a flyer about the research study at the end of their consultation and will briefly explain the study aim and purpose. Following this, the ICC Service Clinical Nurse Specialists (CNS) and the primary researcher will identify patients who meet the inclusion and exclusion criteria and all patients who are eligible to take part will be contact by a CNS shortly after a child receives a diagnosis to follow up with the family, and ask permission for the primary researcher to contact the child's parents to discuss the study.
- BEHAVIORAL
-
Interview
Families who wish to take part will be invited to participate in an interview 2-3 months after they received the diagnosis from the hospital. At least ten families (and therefore at least 30 individuals including children with the diagnosis, parents and siblings) will be interviewed separately, about their experiences of the communication about the diagnosis to them, their child or their siblings. Younger children may do some drawings with the researcher about their experiences, and the researcher will ask questions about these drawings.Participants can be included even if not all family members wish to take part.
- BEHAVIORAL
-
Validated Questionnaires
Each member of the family will complete the mood and quality of life questionnaires.
- BEHAVIORAL
-
Debrief
At the end of each interview the research will explore with the individual to discuss how they found the experience and answer any questions they might have and review the questionnaires that they completed. The researcher will then meet with children and parents together to discuss the experience as a family.Information will be shared with families about options for accessing support including the paediatric psychology service at the hospital or local support services, if they wish. After the interviews, the researcher will send a letter to participants GP and medical team to inform them that they are taking part.
Sponsors & Collaborators
-
Ben Williams Trust
collaborator OTHER -
Royal Brompton & Harefield NHS Foundation Trust
lead OTHER
Principal Investigators
-
Jan Till, Doctor · Royal Brompton & Harefield NHS Foundation Trust
Study Design
- Allocation
- NA
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 8 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2016-09-30
- Completion
- 2016-09-30
More Related Trials
-
Heart Failure in Adult Patients With a History of Congenital Heart Disease
NCT00208754 ·Status: TERMINATED
-
Examining Developmental Changes in Heart Contractions of Children With Congenital Heart Defects
NCT00860327 ·Status: TERMINATED
-
Genetics of Congenital Heart Disease
NCT01192048 ·Status: RECRUITING
-
Percutaneous Interventions in Adults With CHD
NCT00266916 ·Status: TERMINATED
-
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
NCT01873976 ·Status: UNKNOWN
-
Using Tissue Doppler/Synchronization to Determine Heart Function in Children With Congenital Heart Disease
NCT00208676 ·Status: TERMINATED
-
Pediatric Cardiomyopathy Mutation Analysis
NCT02432092 ·Status: RECRUITING
-
PRecIsion Medicine in CardiomyopathY
NCT04036799 ·Status: ACTIVE_NOT_RECRUITING
-
Pathophysiology of Dilated Cardiomyopathy
NCT02001961 ·Status: WITHDRAWN
-
Recognizing and Treating Psychosocial Stress Among Children With Complex Heart Problems
NCT02002780 ·Status: WITHDRAWN ·Phase: PHASE2
-
Impact of Exercise Training on Single Ventricle Function in Paediatric Fontan Patients
NCT05617534 ·Status: UNKNOWN
-
Microcirculation and Vascular Function After Fontan Surgery
NCT05683067 ·Status: UNKNOWN
-
Evaluating Precision of Therapy - Milrinone
NCT01841177 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarker Study for Heart Failure in Children With Single Ventricle Physiology
NCT00571233 ·Status: COMPLETED
-
Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development
NCT00243776 ·Status: RECRUITING
-
Etiologic Risk Factors of Cardiovascular Malformations
NCT00005153 ·Status: COMPLETED
-
Computer Modeling of Congenital Heart Disease
NCT00366847 ·Status: COMPLETED
-
Functional Muscle Characteristics and Cardio-respiratory Interaction in Patients With Fontan Palliation
NCT04151004 ·Status: COMPLETED ·Phase: NA
-
Barriers to Patients' Early Presentation, Diagnosis and Treatment in Childhood Hydrocephalus
NCT05796713 ·Status: COMPLETED
-
Infant Nasal Nitric Oxide Levels in Congenital Heart Disease
NCT02551107 ·Status: TERMINATED ·Phase: NA
-
Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)
NCT01196182 ·Status: ACTIVE_NOT_RECRUITING
-
Molecular Basis of Congenital Heart Defects
NCT00579358 ·Status: WITHDRAWN
-
Mild Valvar Pulmonary Stenosis
NCT00277927 ·Status: TERMINATED
-
Cerebral Anatomy, Hemodynamics and Metabolism
NCT02919956 ·Status: COMPLETED
-
Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass
NCT04217421 ·Status: RECRUITING ·Phase: PHASE3